This end-to-end platform powers the clinical supply chain, supporting strategic decision making, operations, and enhanced monitoring at both the trial and program levels.
Our team of experts helps pharma companies make better strategic decisions, mitigate risks, manage crisis situations, and optimize processes.
The latest insights from N-SIDE
Testing different lot size scenarios can reduce manufacturing costs and drug waste. We explain how using real-world examples in this resource.
Treating lot sizes as fixed quantities results in high costs and unnecessary waste. When planners gain the ability to test different lot sizes, they can…
When N-SIDE optimized lot sizes for one top pharmaceutical company, they realized 10.5M€ in savings from reduced manufacturing costs (an 11% decrease). Download the whitepaper for details.